Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
Authors
A. Chan
R. Remington
E. Kotyla
A. Lepore
J. Zemianek
T. B. Shea
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 3/2010
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-010-0054-5

Other articles of this Issue 3/2010

The journal of nutrition, health & aging 3/2010 Go to the issue

JNHA: Clinical Neurosciences

Sleep disturbances in nursing homes

JNHA: Geriatric Science

Sleep and dementia

Reproducibility of 24-Hour Dietary Recall for Vitamin Intakes

Reproducibility of 24-hour dietary recall for vitamin intakes by middle-aged Japanese men and women

JNHA: Nutrition

A modified mini nutritional assessment without BMI predicts nsutritional status of community-living elderly in Taiwan

JNHA: Clinical Neurosciences

Non-pharmacologic management of sleep disturbance in Alzheimer’s disease

OriginalPaper

Changes in resting metabolic rate in an elderly German population: Cross-sectional and longitudinal data

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits